In silico discovery of beta-secretase inhibitors

Journal of the American Chemical Society
Danzhi HuangAmedeo Caflisch

Abstract

Alzheimer's disease, the most common amyloid-associated disorder, accounts for the majority of the dementia diagnosed after the age of 60. The cleavage of the beta-amyloid precursor protein is initiated by beta-secretase (BACE-1), a membrane-bound aspartic protease, which has emerged as an important but difficult protein target. Here, an in silico screening approach consisting of fragment-based docking, ligand conformational search by a genetic algorithm, and evaluation of free energy of binding was used to identify low-molecular-weight inhibitors of BACE-1. More than 300,000 small molecules were docked and about 15,000 prioritized according to a linear interaction energy model with evaluation of solvation by continuum electrostatics. Eighty-eight compounds were tested in vitro, and 10 of them showed an IC(50) value lower than 100 microM in a BACE-1 enzymatic assay. Interestingly, the 10 active compounds shared a triazine scaffold. Moreover, four of them were active in an assay with mammalian cells (EC(50) < 20 microM), indicating that they are cell-permeable. Therefore, these triazine derivatives are very promising lead candidates for BACE-1 inhibition. The discoveries of this series and two other series of nonpeptidic BACE-1 ...Continue Reading

References

Jun 5, 1982·Journal of Molecular Biology·J Warwicker, H C Watson
Mar 1, 1994·Protein Engineering·J AqvistJ E Samuelsson
Aug 25, 2001·Journal of Medicinal Chemistry·A K GhoshJ Tang
Nov 2, 2001·Biological Chemistry·N BudinA Caflisch
Dec 14, 2001·The Journal of Biological Chemistry·Fiona Grüninger-LeitchHeinz Döbeli
Apr 23, 2002·Current Topics in Medicinal Chemistry·Silvio Roggo
Dec 30, 2003·Journal of Computational Chemistry·Marco CecchiniAmedeo Caflisch
Apr 23, 2004·Trends in Pharmacological Sciences·Martin Citron
Jul 17, 2004·Biological Chemistry·Oliver MiddendorpAlcide Barberis
Sep 29, 2004·Journal of Molecular Biology·Sahil PatelJeff Yon
Oct 1, 2004·Journal of Medicinal Chemistry·Ramkumar Rajamani, Charles H Reynolds
Dec 14, 2004·Journal of Medicinal Chemistry·Shawn J StachelJoseph P Vacca
Feb 15, 2005·Drug Discovery Today·Matthew T Stahl
Apr 21, 2005·The Journal of Biological Chemistry·Lars PradeDaniel Bur
Sep 16, 2005·Journal of Medicinal Chemistry·Karolina ErsmarkAnders Hallberg
Oct 12, 2005·Structure·Alemayehu A Gorfe, Amedeo Caflisch

❮ Previous
Next ❯

Citations

May 4, 2013·Journal of Computer-aided Molecular Design·José L DomínguezFredy Sussman
Jun 7, 2013·Interdisciplinary Sciences, Computational Life Sciences·Karthikeyan MuthusamyMuthuswamy Anusuyadevi
Oct 15, 2013·Chemical Reviews·Jacques RoudenJérôme Baudoux
Feb 5, 2013·Journal of Medicinal Chemistry·N Yi MokColin W G Fishwick
Jun 1, 2011·Nucleic Acids Research·Aurélien GrosdidierOlivier Michielin
Jan 23, 2009·PLoS Neglected Tropical Diseases·Dariusz EkonomiukDanzhi Huang
Mar 25, 2011·Future Medicinal Chemistry·Obdulia RabalJulen Oyarzabal
Apr 20, 2011·Analytical and Bioanalytical Chemistry·Francesca ManciniVincenza Andrisano
Apr 1, 2009·Expert Opinion on Drug Discovery·Yoshio Hamada, Yoshiaki Kiso
Apr 10, 2013·Expert Opinion on Drug Discovery·Yoshio Hamada, Yoshiaki Kiso
Sep 18, 2008·Protein Science : a Publication of the Protein Society·Patricia SchenkerAntonio Baici
Sep 1, 2009·Journal of Molecular Recognition : JMR·Danzhi Huang, Amedeo Caflisch
Dec 9, 2014·Biotechnology Advances·Vojtech SpiwokPetr Hosek
May 28, 2009·ChemMedChem·Ran Friedman, Amedeo Caflisch
Aug 12, 2014·European Journal of Medicinal Chemistry·Hongtao Zhao, Amedeo Caflisch
Jun 16, 2017·Journal of Biomolecular Structure & Dynamics·Prabu Manoharan, Nanda Ghoshal
May 5, 2011·Journal of Computational Chemistry·Vincent ZoeteOlivier Michielin
Oct 2, 2012·Angewandte Chemie·Drew S FolkKatherine J Franz
May 15, 2013·The Journal of Biological Chemistry·Cindy BenodRobert J Fletterick
Apr 3, 2014·Chemical Society Reviews·Arun K Ghosh, Heather L Osswald
Oct 12, 2017·Frontiers in Molecular Biosciences·Nicolas PanelThomas Simonson
Aug 21, 2020·Current Topics in Medicinal Chemistry·Martin KrátkýJarmila Vinšová
Nov 18, 2017·Current Opinion in Structural Biology·Paweł Śledź, Amedeo Caflisch
Jun 27, 2008·Journal of Medicinal Chemistry·Ting ZhouAmedeo Caflisch
Sep 18, 2009·Journal of Medicinal Chemistry·Michael S MalamasAlbert J Robichaud
Feb 10, 2009·Journal of Chemical Theory and Computation·Göran WallinJohan Åqvist
Aug 18, 2010·Journal of Chemical Information and Modeling·Kanin WichapongWolfgang Sippl
Sep 2, 2017·Journal of Chemical Information and Modeling·Jean-Rémy MarchandAmedeo Caflisch
Aug 28, 2007·Neurochemistry International·Neville Marks, Martin J Berg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.